Cargando…
Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations
A physiologically based pharmacokinetic (PBPK) model of selegiline (SEL), and its metabolites, was developed in silico to evaluate the disposition differences between healthy and special populations. SEL is metabolized to methamphetamine (MAP) and desmethyl selegiline (DMS) by several CYP enzymes. C...
Autores principales: | Puttrevu, Santosh Kumar, Arora, Sumit, Polak, Sebastian, Patel, Nikunj Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600566/ https://www.ncbi.nlm.nih.gov/pubmed/33008144 http://dx.doi.org/10.3390/pharmaceutics12100942 |
Ejemplares similares
-
Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007) -
Physiologically
Based Pharmacokinetic
Model To Predict Metoprolol Disposition in Healthy and Disease Populations
por: Zamir, Ammara, et al.
Publicado: (2023) -
A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion
por: Harris, Debra S, et al.
Publicado: (2009) -
Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019) -
Preclinical Herb–Drug Pharmacokinetic Interaction
of Panax ginseng Extract and Selegiline
in Freely Moving Rats
por: Yang, Ling, et al.
Publicado: (2020)